ClinicalTrials.Veeva

Menu

Predictors of Node Positivity in Endometrial Cancer

F

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Status

Enrolling

Conditions

Endometrial Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To investigate the role of histological and moleculr profile of endometrial cancer patietns in predicting the risk of nodal metastases in endometrila cancer patients.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Histologically confirmed endometrila cancer
  • Data on molecular genomic profiling (POLE mutated, p53 abnormalities, MMRd/MSI-H, and NSMP)
  • Data on histological characteristics of the ttumor
  • Execution of sentinel node mapping
  • Data on sentinel node status (negative vs. positive)

Exclusion criteria

  • Stage IVB endoemtrial cancer
  • consent withdraw

Trial contacts and locations

1

Loading...

Central trial contact

Grazia M Casadei, ph.d.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems